Carl Sterritt
Algemeen Directeur bij Phosphate Therapeutics Ltd.
Actieve functies van Carl Sterritt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Algemeen Directeur | - | - |
Loopbaan van Carl Sterritt
Eerdere bekende functies van Carl Sterritt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHIELD THERAPEUTICS PLC | Directeur/Bestuurslid | 01-01-2008 | 22-04-2020 |
| Algemeen Directeur | 01-01-2008 | 22-04-2020 | |
| Oprichter | 01-01-2008 | 22-04-2020 | |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01-01-2006 | - |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Directeur/Bestuurslid | 02-06-2011 | 04-02-2015 |
| Algemeen Directeur | 02-06-2011 | - | |
| Voorzitter | - | - | |
| Oprichter | 01-01-2008 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 2 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 6 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Carl Sterritt
- Ervaring
